![](/img/cover-not-exists.png)
Cost Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared to Monotherapy for Metastatic Melanoma from a US Societal Perspective
Tran, DM, McDowell, LC, Oh, A, Barcelon, JA, Keyvani, D, Merino, O, Wilson, LVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.03.502
Date:
May, 2016
File:
PDF, 65 KB
english, 2016